{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:37:43Z","timestamp":1792143463818,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T00:00:00Z","timestamp":1567382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T00:00:00Z","timestamp":1567382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670167"],"award-info":[{"award-number":["81670167"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81621001"],"award-info":[{"award-number":["81621001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81530046"],"award-info":[{"award-number":["81530046"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13045-019-0775-9","type":"journal-article","created":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T18:09:38Z","timestamp":1567447778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study"],"prefix":"10.1186","volume":"12","author":[{"given":"Lan-Ping","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ru","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Jun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jian","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Hua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2145-6643","authenticated-orcid":false,"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,2]]},"reference":[{"key":"775_CR1","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1182\/blood-2016-08-693481","volume":"129","author":"A Bacigalupo","year":"2017","unstructured":"Bacigalupo A. How I treat acquired aplastic anemia. Blood. 2017;129:1428\u201336.","journal-title":"Blood"},{"key":"775_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/bjh.13853","volume":"172","author":"SB Killick","year":"2016","unstructured":"Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A, et al. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2016;172:187\u2013207.","journal-title":"Br J Haematol"},{"key":"775_CR3","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.bbmt.2014.06.028","volume":"20","author":"J Clay","year":"2014","unstructured":"Clay J, Kulasekararaj AG, Potter V, Grimaldi F, McLornan D, Raj K, et al. Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia. Biol Blood Marrow Transpl. 2014;20:1711\u20136.","journal-title":"Biol Blood Marrow Transpl"},{"key":"775_CR4","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/bmt.2010.213","volume":"46","author":"AE Dezern","year":"2011","unstructured":"Dezern AE, Luznik L, Fuchs EJ, Jones RJ, Brodsky RA. Post-transplantation cyclophosphamide for GVHD prophylaxis in severe aplastic anemia. Bone Marrow Transpl. 2011;46:1012\u20133.","journal-title":"Bone Marrow Transpl"},{"key":"775_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/bmt.2015.20","volume":"50","author":"I Esteves","year":"2015","unstructured":"Esteves I, Bonfim C, Pasquini R, Funke V, Pereira NF, Rocha V, et al. Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study. Bone Marrow Transpl. 2015;50:685\u20139.","journal-title":"Bone Marrow Transpl"},{"key":"775_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/bmt.2013.224","volume":"49","author":"L Gao","year":"2014","unstructured":"Gao L, Li Y, Zhang Y, Chen X, Gao L, Zhang C, et al. Long-term outcome of HLA-haploidentical hematopoietic SCT without in vitro T-cell depletion for adult severe aplastic anemia after modified conditioning and supportive therapy. Bone Marrow Transpl. 2014;49:519\u201324.","journal-title":"Bone Marrow Transpl"},{"key":"775_CR7","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/sj.bmt.1705299","volume":"37","author":"JR Passweg","year":"2006","unstructured":"Passweg JR, Perez WS, Eapen M, Camitta BM, Gluckman E, Hinterberger W, et al. Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. Bone Marrow Transpl. 2006;37:641\u20139.","journal-title":"Bone Marrow Transpl"},{"key":"775_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-017-0398-y","volume":"10","author":"LP Xu","year":"2017","unstructured":"Xu LP, Jin S, Wang SQ, Xia LH, Bai H, Gao SJ, et al. Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant. J Hematol Oncol. 2017;10:25.","journal-title":"J Hematol Oncol"},{"key":"775_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/bjh.14225","volume":"175","author":"LP Xu","year":"2016","unstructured":"Xu LP, Wang SQ, Wu DP, Wang JM, Gao SJ, Jiang M, et al. Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study. Br J Haematol. 2016;175:265\u201374.","journal-title":"Br J Haematol"},{"key":"775_CR10","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/bmt.2017.237","volume":"53","author":"LP Xu","year":"2018","unstructured":"Xu LP, Xu ZL, Wang FR, Mo XD, Han TT, Han W, et al. Unmanipulated haploidentical transplantation conditioning with busulfan, cyclophosphamide and anti-thymoglobulin for adult severe aplastic anaemia. Bone Marrow Transpl. 2018;53:188\u201392.","journal-title":"Bone Marrow Transpl"},{"key":"775_CR11","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1182\/blood-2014-03-563130","volume":"124","author":"Y Wang","year":"2014","unstructured":"Wang Y, Chang YJ, Xu LP, Liu KY, Liu DH, Zhang XH, et al. Who is the best donor for a related HLA haplotype-mismatched transplant? Blood. 2014;124:843\u201350.","journal-title":"Blood"},{"key":"775_CR12","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.bbmt.2012.08.007","volume":"19","author":"SO Ciurea","year":"2013","unstructured":"Ciurea SO, Champlin RE. Donor selection in T cell-replete haploidentical hematopoietic stem cell transplantation: knowns, unknowns, and controversies. Biol Blood Marrow Transpl. 2013;19:180\u20134.","journal-title":"Biol Blood Marrow Transpl"},{"key":"775_CR13","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bbmt.2009.11.011","volume":"16","author":"YL Kasamon","year":"2010","unstructured":"Kasamon YL, Luznik L, Leffell MS, Kowalski J, Tsai HL, Bolanos-Meade J, et al. Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome. Biol Blood Marrow Transpl. 2010;16:482\u20139.","journal-title":"Biol Blood Marrow Transpl"},{"key":"775_CR14","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1182\/blood.V100.3.799","volume":"100","author":"S Kojima","year":"2002","unstructured":"Kojima S, Matsuyama T, Kato S, Kigasawa H, Kobayashi R, Kikuta A, et al. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Blood. 2002;100:799\u2013803.","journal-title":"Blood"},{"key":"775_CR15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/01.tp.0000226156.99206.d1","volume":"82","author":"M Stern","year":"2006","unstructured":"Stern M, Passweg JR, Locasciulli A, Socie G, Schrezenmeier H, Bekassy AN, et al. Influence of donor\/recipient sex matching on outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia. Transplantation. 2006;82:218\u201326.","journal-title":"Transplantation"},{"key":"775_CR16","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3324\/haematol.2015.139469","volume":"101","author":"Y Arai","year":"2016","unstructured":"Arai Y, Kondo T, Yamazaki H, Takenaka K, Sugita J, Kobayashi T, et al. Allogeneic unrelated bone marrow transplantation from older donors results in worse prognosis in recipients with aplastic anemia. Haematologica. 2016;101:644\u201352.","journal-title":"Haematologica"},{"key":"775_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1399-0012.2011.01499.x","volume":"26","author":"M-R Huo","year":"2012","unstructured":"Huo M-R, Xu L-P, Li D, Liu D-H, Liu K-Y, Chen H, et al. The effect of HLA disparity on clinical outcome after HLA-haploidentical blood and marrow transplantation. Clin Transplant. 2012;26:284\u201391.","journal-title":"Clin Transplant"},{"key":"775_CR18","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1182\/blood-2005-05-2146","volume":"107","author":"D-P Lu","year":"2006","unstructured":"Lu D-P, Dong L, Wu T, Huang X-J, Zhang M-J, Han W, et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched\/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood. 2006;107:3065\u201373.","journal-title":"Blood"},{"key":"775_CR19","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1080\/07853890801908903","volume":"40","author":"H Xiao-Jun","year":"2008","unstructured":"Xiao-Jun H, Lan-Ping X, Kai-Yan L, Dai-Hong L, Huan C, Wei H, et al. HLA-mismatched\/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase. Ann Med. 2008;40:444\u201355.","journal-title":"Ann Med"},{"key":"775_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.transci.2018.04.014","volume":"57","author":"ZN Ozdemir","year":"2018","unstructured":"Ozdemir ZN, Civriz Bozdag S. Graft failure after allogeneic hematopoietic stem cell transplantation. Transfus Apher Sci. 2018;57:163\u20137.","journal-title":"Transfus Apher Sci"},{"key":"775_CR21","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/bmt.2009.378","volume":"45","author":"H Yagasaki","year":"2010","unstructured":"Yagasaki H, Takahashi Y, Hama A, Kudo K, Nishio N, Muramatsu H, et al. Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia. Bone Marrow Transpl. 2010;45:1508\u201313.","journal-title":"Bone Marrow Transpl"},{"key":"775_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/bmt.2016.223","volume":"52","author":"YB Choi","year":"2017","unstructured":"Choi YB, Yi ES, Lee JW, Sung KW, Koo HH, Yoo KH. Immunosuppressive therapy versus alternative donor hematopoietic stem cell transplantation for children with severe aplastic anemia who lack an HLA-matched familial donor. Bone Marrow Transpl. 2017;52:47\u201352.","journal-title":"Bone Marrow Transpl"},{"key":"775_CR23","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1182\/blood-2014-10-609032","volume":"125","author":"SG Holtan","year":"2015","unstructured":"Holtan SG, DeFor TE, Lazaryan A, Bejanyan N, Arora M, Brunstein CG, et al. Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation. Blood. 2015;125:1333\u20138.","journal-title":"Blood"},{"key":"775_CR24","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transpl. 1995;15:825\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"775_CR25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V57.2.267.267","volume":"57","author":"KM Sullivan","year":"1981","unstructured":"Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB, et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood. 1981;57:267\u201376.","journal-title":"Blood"},{"key":"775_CR26","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1053\/j.seminoncol.2012.09.005","volume":"39","author":"L Luznik","year":"2012","unstructured":"Luznik L, O\u2019Donnell PV, Fuchs EJ. Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation. Semin Oncol. 2012;39:683\u201393.","journal-title":"Semin Oncol"},{"key":"775_CR27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0171-2985(96)80033-7","volume":"195","author":"H Mayumi","year":"1996","unstructured":"Mayumi H, Umesue M, Nomoto K. Cyclophosphamide-induced immunological tolerance: an overview. Immunobiology. 1996;195:129\u201339.","journal-title":"Immunobiology"},{"key":"775_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3121\/cmr.2.4.243","volume":"2","author":"T Iwasaki","year":"2004","unstructured":"Iwasaki T. Recent advances in the treatment of graft-versus-host disease. Clin Med Res. 2004;2:243\u201352.","journal-title":"Clin Med Res"},{"key":"775_CR29","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/bmt.2012.79","volume":"47","author":"LP Xu","year":"2012","unstructured":"Xu LP, Liu KY, Liu DH, Han W, Chen H, Chen YH, et al. A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemia. Bone Marrow Transpl. 2012;47:1507\u201312.","journal-title":"Bone Marrow Transpl"},{"key":"775_CR30","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1200\/JCO.2015.63.8817","volume":"34","author":"YJ Chang","year":"2016","unstructured":"Chang YJ, Xu LP, Wang Y, Zhang XH, Chen H, Chen YH, et al. Controlled, randomized, open-label trial of risk-stratified corticosteroid prevention of acute graft-versus-host disease after haploidentical transplantation. J Clin Oncol. 2016;34:1855\u201363.","journal-title":"J Clin Oncol"},{"key":"775_CR31","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.bbmt.2009.07.002","volume":"15","author":"K Ludajic","year":"2009","unstructured":"Ludajic K, Balavarca Y, Bickeboller H, Rosenmayr A, Fischer GF, Fae I, et al. Minor ABO-mismatches are risk factors for acute graft-versus-host disease in hematopoietic stem cell transplant patients. Biol Blood Marrow Transpl. 2009;15:1400\u20136.","journal-title":"Biol Blood Marrow Transpl"},{"key":"775_CR32","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1016\/j.transproceed.2009.06.189","volume":"41","author":"ZN Ozkurt","year":"2009","unstructured":"Ozkurt ZN, Yegin ZA, Yenicesu I, Aki SZ, Yagci M, Sucak GT. Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation. Transpl Proc. 2009;41:3851\u20138.","journal-title":"Transpl Proc"},{"key":"775_CR33","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.3324\/haematol.12933","volume":"93","author":"F Kimura","year":"2008","unstructured":"Kimura F, Sato K, Kobayashi S, Ikeda T, Sao H, Okamoto S, et al. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program. Haematologica. 2008;93:1686\u201393.","journal-title":"Haematologica"},{"key":"775_CR34","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.bbmt.2017.02.009","volume":"23","author":"S Damodar","year":"2017","unstructured":"Damodar S, Shanley R, MacMillan M, Ustun C, Weisdorf D. Donor-to-recipient ABO mismatch does not impact outcomes of allogeneic hematopoietic cell transplantation regardless of graft source. Biol Blood Marrow Transpl. 2017;23:795\u2013804.","journal-title":"Biol Blood Marrow Transpl"},{"key":"775_CR35","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1111\/j.1537-2995.2004.04106.x","volume":"44","author":"C Canals","year":"2004","unstructured":"Canals C, Muniz-Diaz E, Martinez C, Martino R, Moreno I, Ramos A, et al. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning. Transfusion (Paris). 2004;44:1603\u201311.","journal-title":"Transfusion (Paris)"},{"key":"775_CR36","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/ajh.24771","volume":"92","author":"J Canaani","year":"2017","unstructured":"Canaani J, Savani BN, Labopin M, Michallet M, Craddock C, Socie G, et al. ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: a report from the acute leukemia working party of the EBMT. Am J Hematol. 2017;92:789\u201396.","journal-title":"Am J Hematol"},{"key":"775_CR37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/bmt.2017.224","volume":"53","author":"L-Q Cao","year":"2018","unstructured":"Cao L-Q, Liu L, Xu L-P, Zhang X-H, Wang Y, Fan Q-Z, et al. Correlation between pediatric donor characteristics and cell compositions in mixture allografts of combined G-CSF-mobilized PBSCs and bone marrow allografts. Bone Marrow Transplant. 2018;53:108\u201310.","journal-title":"Bone Marrow Transplant"},{"key":"775_CR38","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1111\/trf.13251","volume":"55","author":"Y-T Wang","year":"2015","unstructured":"Wang Y-T, Zhao X-Y, Zhao X-S, Xu L-P, Zhang X-H, Wang Y, et al. The impact of donor characteristics on the immune cell composition of mixture allografts of granulocyte-colony-stimulating factor-mobilized marrow harvests and peripheral blood harvests. Transfusion (Paris). 2015;55:2874\u201381.","journal-title":"Transfusion (Paris)"},{"key":"775_CR39","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1182\/blood-2008-03-143677","volume":"112","author":"S Vasu","year":"2008","unstructured":"Vasu S, Leitman SF, Tisdale JF, Hsieh MM, Childs RW, Barrett AJ, et al. Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population. Blood. 2008;112:2092\u2013100.","journal-title":"Blood"},{"key":"775_CR40","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/trf.12238","volume":"54","author":"J Chen","year":"2014","unstructured":"Chen J, Burns KM, Babic A, Carrum G, Kennedy M, Segura FJ, et al. Donor body mass index is an important factor that affects peripheral blood progenitor cell yield in healthy donors after mobilization with granulocyte-colony-stimulating factor. Transfusion (Paris). 2014;54:203\u201310.","journal-title":"Transfusion (Paris)"},{"key":"775_CR41","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3324\/haematol.2016.147645","volume":"101","author":"HT Kim","year":"2016","unstructured":"Kim HT, Zhang MJ, Woolfrey AE, St Martin A, Chen J, Saber W, et al. Donor and recipient sex in allogeneic stem cell transplantation: what really matters. Haematologica. 2016;101:1260\u20136.","journal-title":"Haematologica"},{"key":"775_CR42","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1182\/blood-2003-07-2603","volume":"103","author":"SS Randolph","year":"2004","unstructured":"Randolph SS, Gooley TA, Warren EH, Appelbaum FR, Riddell SR. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood. 2004;103:347\u201352.","journal-title":"Blood"}],"container-title":["Journal of Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-019-0775-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13045-019-0775-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-019-0775-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T23:33:40Z","timestamp":1598916820000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-019-0775-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,2]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["775"],"URL":"https:\/\/doi.org\/10.1186\/s13045-019-0775-9","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,2]]},"assertion":[{"value":"6 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by each institutional review board at the three participating institutions, and written informed consent was obtained from all subjects in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}